ceda-research
- Address
- Neue Mitte 10, Haus 4, Watzenborn-Steinberg, Hessen, 35415 Pohlheim, Germany
CEDA-Research - Metabolic Disease Clinical Research Center
CEDA-Research is a specialized clinical research facility focused on advancing therapeutic interventions for metabolic disorders. The center demonstrates particular expertise in conducting pivotal trials for obesity and type 2 diabetes, contributing to the development of novel pharmacological approaches for weight management and glycemic control in adult populations.
- Weight management and obesity therapeutics research
- Type 2 diabetes treatment development
- Cardiometabolic disease interventions
The research center participates in large-scale efficacy studies evaluating innovative treatments such as orforglipron (LY3502970), investigating their superiority over placebo in achieving clinically meaningful body weight reduction. CEDA-Research's involvement in the ATTAIN-2 study demonstrates their capability to conduct rigorous placebo-controlled trials assessing metabolic outcomes in patients with combined metabolic conditions, including overweight and diabetic populations.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ceda-research
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| J2A-MC-GZGQ: A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2) | Eli Lilly & Co. | Phase III | Not Recruiting | Sep 2023 | Aug 2025 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.